Fujiki H[Author] - Search Results

Year	Number of Results
1966	2
1967	1
1968	1
1969	1
1970	1
1972	1
1975	3
1976	1
1977	3
1978	2
1979	4
1980	4
1981	8
1982	11
1983	19
1984	15
1985	9
1986	21
1987	13
1988	17
1989	17
1990	20
1991	10
1992	19
1993	11
1994	5
1995	6
1996	12
1997	7
1998	9
1999	17
2000	6
2001	12
2002	6
2003	4
2004	5
2005	6
2006	7
2007	7
2008	5
2009	2
2010	8
2011	7
2012	6
2013	6
2014	7
2015	4
2016	1
2017	4
2018	7
2019	3
2020	5
2021	2
2022	5
2023	4
2024	1

1

Cancer progression by the okadaic acid class of tumor promoters and endogenous protein inhibitors of PP2A, SET and CIP2A.

Fujiki H, Sueoka E, Watanabe T, Komori A, Suganuma M. Fujiki H, et al. J Cancer Res Clin Oncol. 2023 Sep;149(11):9425-9433. doi: 10.1007/s00432-023-04800-4. Epub 2023 Apr 25. J Cancer Res Clin Oncol. 2023. PMID: 37097392 Free PMC article. Review.

2

Anticarcinogenic effects of (-)-epigallocatechin gallate.

Fujiki H, Yoshizawa S, Horiuchi T, Suganuma M, Yatsunami J, Nishiwaki S, Okabe S, Nishiwaki-Matsushima R, Okuda T, Sugimura T. Fujiki H, et al. Prev Med. 1992 Jul;21(4):503-9. doi: 10.1016/0091-7435(92)90057-o. Prev Med. 1992. PMID: 1409491 Review.

3

Role of TNF-α-Inducing Protein Secreted by Helicobacter pylori as a Tumor Promoter in Gastric Cancer and Emerging Preventive Strategies.

Suganuma M, Watanabe T, Sueoka E, Lim IK, Fujiki H. Suganuma M, et al. Among authors: fujiki h. Toxins (Basel). 2021 Mar 1;13(3):181. doi: 10.3390/toxins13030181. Toxins (Basel). 2021. PMID: 33804551 Free PMC article. Review.

4

Green tea: cancer preventive beverage and/or drug.

Fujiki H, Suganuma M, Imai K, Nakachi K. Fujiki H, et al. Cancer Lett. 2002 Dec 15;188(1-2):9-13. doi: 10.1016/s0304-3835(02)00379-8. Cancer Lett. 2002. PMID: 12406542 Review.

5

Tumor promoters--microcystin-LR, nodularin and TNF-α and human cancer development.

Fujiki H, Suganuma M. Fujiki H, et al. Anticancer Agents Med Chem. 2011 Jan;11(1):4-18. doi: 10.2174/187152011794941163. Anticancer Agents Med Chem. 2011. PMID: 21269254 Review.

6

Tumor promoters: from chemicals to inflammatory proteins.

Fujiki H, Sueoka E, Suganuma M. Fujiki H, et al. J Cancer Res Clin Oncol. 2013 Oct;139(10):1603-14. doi: 10.1007/s00432-013-1455-8. Epub 2013 Jun 12. J Cancer Res Clin Oncol. 2013. PMID: 23756937 Review.

7

Carcinogenic aspects of protein phosphatase 1 and 2A inhibitors.

Fujiki H, Suganuma M. Fujiki H, et al. Prog Mol Subcell Biol. 2009;46:221-54. doi: 10.1007/978-3-540-87895-7_8. Prog Mol Subcell Biol. 2009. PMID: 19184590 Review.

8

Human cancer stem cells are a target for cancer prevention using (-)-epigallocatechin gallate.

Fujiki H, Sueoka E, Rawangkan A, Suganuma M. Fujiki H, et al. J Cancer Res Clin Oncol. 2017 Dec;143(12):2401-2412. doi: 10.1007/s00432-017-2515-2. Epub 2017 Sep 23. J Cancer Res Clin Oncol. 2017. PMID: 28942499 Free PMC article. Review.

9

Human gastric cancer development with TNF-α-inducing protein secreted from Helicobacter pylori.

Suganuma M, Watanabe T, Yamaguchi K, Takahashi A, Fujiki H. Suganuma M, et al. Among authors: fujiki h. Cancer Lett. 2012 Sep 28;322(2):133-8. doi: 10.1016/j.canlet.2012.03.027. Epub 2012 Mar 27. Cancer Lett. 2012. PMID: 22459353 Review.

10

Biophysical Approach to Mechanisms of Cancer Prevention and Treatment with Green Tea Catechins.

Suganuma M, Takahashi A, Watanabe T, Iida K, Matsuzaki T, Yoshikawa HY, Fujiki H. Suganuma M, et al. Among authors: fujiki h. Molecules. 2016 Nov 18;21(11):1566. doi: 10.3390/molecules21111566. Molecules. 2016. PMID: 27869750 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

388 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

388 results

Results by year